Children’s Symptoms with a Febrile Illness and a Positive or Negative Test of SARS-CoV-2 during the Omicron Wave

Febrile infections are common in childhood. Children can be infected with SARS-CoV-2, but their course is milder than in adults. So far, a comparison between febrile infections with a positive or negative Corona test with the Omicron variant is missing. The data used are from the FeverApp registry, which collects parent-reported data on febrile infections in children and informs about fever management. A comparison of symptomatic differences between episodes with a positive or negative Corona test was performed using Χ2-tests. During the Omicron wave, reported tests doubled and positive test results nearly 12-folded. In episodes with positive Corona saliva tests, more cough, fatigue, disturbed smell/taste, limb pain, sore throat, signs of serious sickness, and touch sensitivity were reported. Children with a negative Corona test show more tonsillitis, teething, any pain symptoms, earaches, and rashes. Thus, there are some significant differences between febrile infections with a positive or negative Corona test, but symptoms are present on both sides. The omicron variant seems to be more infectious than the alpha or delta variants in children, but the symptoms remain mild and do not differ much from other febrile infections.

[1]  Yongdai Kim,et al.  Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529) , 2022, BMC Medicine.

[2]  E. Jenetzky,et al.  Data Completeness and Concordance in the FeverApp Registry: Comparative Study , 2022, JMIR pediatrics and parenting.

[3]  H. Triki,et al.  SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era , 2022, Virology journal.

[4]  D. Clifton,et al.  Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom , 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[5]  M. Peiris,et al.  Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract , 2022, eBioMedicine.

[6]  C. Lehmann,et al.  Clinical Aspects of the Subsequent SARS-CoV-2 Waves in Children from 2020 to 2022—Data from a Local Cohort in Cologne, Germany (n = 21,635) , 2022, Viruses.

[7]  G. Thouvenin,et al.  SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant , 2022, Frontiers in Pediatrics.

[8]  W. Haas,et al.  SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  L. Abu-Raddad,et al.  COVID-19 Disease Severity in Children Infected with the Omicron Variant , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  H. Ullum,et al.  Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study , 2022, The Lancet Infectious Diseases.

[11]  A. Tagarro,et al.  Features of COVID-19 in Children During the Omicron Wave Compared With Previous Waves in Madrid, Spain , 2022, The Pediatric infectious disease journal.

[12]  S. Bhatt,et al.  Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.

[13]  W. Schaffner,et al.  Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[14]  A. Goga,et al.  Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study , 2022, The Lancet Child & Adolescent Health.

[15]  L. Poon,et al.  SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo , 2022, Nature.

[16]  G. Wei,et al.  Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance , 2022, J. Chem. Inf. Model..

[17]  R. Mukherjee,et al.  Why are some coronavirus variants more infectious? , 2021, Journal of Biosciences.

[18]  M. Balaguer,et al.  The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit , 2021, BMC Infectious Diseases.

[19]  C. Murray,et al.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.

[20]  T. Skoff,et al.  Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[21]  R. Laxer,et al.  Approach to recurrent fever in childhood. , 2017, Canadian family physician Medecin de famille canadien.